Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Pros and cons of making researchers and the state responsible

From: Who should pay for the continuity of post-trial health care treatments?

Researches and State
Pros Cons
Inclusion of clinical trials in public health policy Inconsistent with official procedures to cover drugs with proven evidence
Prioritize disease research Could make the cost of clinical trials in the country prohibitive.
State could impose conditions for the study May require change in legislation
Guaranteed completion of the study  
State could request / obtain best price  
Greater transparency